SCHEMBL1090973

SCHEMBL1090973

Cc1cnc(CNc2nc(N3CCc4ccccc4C3)c3ccccc3n2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.48
CYP1A2 P05177 12/20 0.46
CYP3A4 P08684 12/20 0.46
CYP2D6 P10635 8/20 0.46
ALDH1A1 P00352 7/20 0.46
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
HSD17B10 Q99714 4/20 0.46
USP2 O75604 3/20 0.46
CLK4 Q9HAZ1 3/20 0.46
TSHR P16473 3/20 0.45
CYP2C19 P33261 7/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
KDM4E B2RXH2 5/20 0.43
MAPT P10636 4/20 0.43
HPGD P15428 3/20 0.43
LMNA P02545 2/20 0.43
TP53 P04637 2/20 0.43
MAPK1 P28482 2/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1091416 0.85 MRGPRX1 (0.54) CYP1A2CYP3A4CYP2D6ALDH1A1MEN1
SCHEMBL1089112 0.84 GBA1 (0.51) GBA1ALDH1A1MEN1KMT2ATSHR
SCHEMBL1090480 0.84 KMT2A (0.53) CYP1A2CYP3A4CYP2D6ALDH1A1MEN1
SCHEMBL1089796 0.84 KMT2A (0.53) CYP1A2CYP3A4CYP2D6ALDH1A1MEN1
SCHEMBL1090757 0.84 KMT2A (0.53) CYP1A2CYP3A4CYP2D6ALDH1A1MEN1
SCHEMBL1090896 0.82 GBA1 (0.53) GBA1ALDH1A1KMT2AKDM4EMAPT
SCHEMBL1090259 0.82 CYP1A2 (0.50) CYP1A2CYP3A4CYP2D6ALDH1A1MEN1
SCHEMBL1090535 0.79 HRH4 (0.51) GBA1ALDH1A1MEN1KMT2AHSD17B10
SCHEMBL1091226 0.78 GBA1 (0.48) GBA1CYP1A2CYP3A4ALDH1A1MEN1
SCHEMBL2947363 0.78 ADAMTS4 (0.51) GBA1ALDH1A1SMN1; SMN2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GBA1 3584/4885CYP1A2 1368/4885CYP3A4 1092/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 GBA1 3584/4885CYP1A2 1368/4885CYP3A4 1092/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 GBA1 3584/4885CYP1A2 1368/4885CYP3A4 1092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.